phenytoin has been researched along with 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Borosky, S; Marcoux, FW; Probert, AW; Taylor, CP | 1 |
2 other study(ies) available for phenytoin and 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Sodium channel modulators prevent oxygen and glucose deprivation injury and glutamate release in rat neocortical cultures.
Topics: Animals; Calcium; Cell Death; Cell Hypoxia; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Antagonists; Glucose; Glutamic Acid; L-Lactate Dehydrogenase; Lidocaine; Neurons; Phenytoin; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sodium Channel Blockers; Tetrodotoxin | 1997 |